Theta Burst Stimulation for Motor Recovery
Comparative Efficacy of Different Doses of Theta Burst Stimulation for Motor Recovery in Stroke Patients
National Taiwan University Hospital
60 participants
Oct 29, 2022
INTERVENTIONAL
Conditions
Summary
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technology. This study will compare efficacy of different doses iTBS in combination with inhibitory rTMS on motor recovery and cortical excitability in subacute stroke patients.
Eligibility
Inclusion Criteria6
- Unilateral ischemic or hemorrhagic stroke
- Stroke within 3 months
- Medical Research Council Scale for Muscle Strength in upper limb ≤ 3
- No previous stroke, seizure, dementia, Parkinson's disease or other degenerative neurological diseases.
- Patient could sit over 15 minutes
- Age over 20
Exclusion Criteria6
- Previous stroke, traumatic brain injury, brain tumor
- With central nervous system disease (spinal cord injury, Parkinson's disease)
- Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker)
- Patients unable to cooperate the treatment
- Pregnancy
- Depression
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technology. High and low frequencies of rTMS could modulate the excitability of the cerebral cortex. Theta burst stimulation (TBS) has achieved a similar effect to traditional rTMS mode. Intermittent TBS (iTBS) could upregulate cortical excitability of the primary motor cortex (M1) and continuous TBS (cTBS) with inhibitory effect.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05613686